Matches in Nanopublications for { ?s ?p "[The presence of high levels of immunoreactive Apo-D in HGPIN and prostate cancer, but not in non-malignant epithelial cells, is consistent with HGPIN being an intermediate lesion in the transition to prostate cancer, and suggests that cellular Apo-D expression is a marker of malignant transformation of the prostate.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP427552.RAWxFW-x77OLiGMvHM0X1ttn6h-jW-kDpI2qJvJZv8GBE130_assertion description "[The presence of high levels of immunoreactive Apo-D in HGPIN and prostate cancer, but not in non-malignant epithelial cells, is consistent with HGPIN being an intermediate lesion in the transition to prostate cancer, and suggests that cellular Apo-D expression is a marker of malignant transformation of the prostate.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427552.RAWxFW-x77OLiGMvHM0X1ttn6h-jW-kDpI2qJvJZv8GBE130_provenance.
- NP244693.RAGuExC6VyKx8dIRecDck1BWGFYbeAUBOs5mIMt5m5O_A130_assertion description "[The presence of high levels of immunoreactive Apo-D in HGPIN and prostate cancer, but not in non-malignant epithelial cells, is consistent with HGPIN being an intermediate lesion in the transition to prostate cancer, and suggests that cellular Apo-D expression is a marker of malignant transformation of the prostate.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244693.RAGuExC6VyKx8dIRecDck1BWGFYbeAUBOs5mIMt5m5O_A130_provenance.